Published on 11/05/2025 at 03:29 am EST
(Reuters) - European shares hit a two-week low on Wednesday as elevated equity valuations continued to make investors nervous globally, while Novo Nordisk slipped after the drugmaker issued a dour forecast.
The pan-european STOXX 600 index fell 0.4% to 568.10, as of 0811 GMT, trading at levels last seen on October 17 for a second straight session.
Technology stocks were top sectoral decliners, falling 1.3%, while stocks often seen as safe-havens such as the food and beverage traded marginally higher.
Valuation fears resurfaced this week on Wall Street and in Asian markets that have had record-breaking runs this year, driven primarily by enthusiasm for artificial intelligence. Comments by major U.S. banks on Tuesday further fuelled these worries.
Meanwhile, earnings were also in focus across the continent.
Novo Nordiskfell 2% in choppy trading after the Wegovy maker lowered its full-year profit forecast in an early blow to the Danish drugmaker's new CEO amid a deep restructuring drive to claw back lost ground in a fierce obesity drug market battle.
Ambuslumped 12% after the Danish endoscopy solutions maker reported quarterly results below consensus
Vestasreported third-quarter operating profit above expectations, sending shares of the wind turbine maker up 10%.
(Reporting by Johann M Cherian in Bengaluru; Editing by Rashmi Aich)
Sumber : Reuters
作者:indopremier_id,文章来源indopremier_id,版权归原作者所有,如有侵权请联系本人删除。
风险提示:本文所述仅代表作者个人观点,不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证,对于基于该内容所采取的任何行为,不承担任何责任,除非另有书面明确说明。
喜欢的话,赞赏支持一下


加载失败()